Dong Fang

Title: The Innovative Contributions of Dong Fang

Introduction

Dong Fang is a notable inventor based in North Potomac, MD (US). He has made significant contributions to the field of cancer research, holding 2 patents that focus on innovative methods and compositions for assessing, treating, and preventing diseases, particularly cancer.

Latest Patents

Dong Fang's latest patents revolve around cancer-associated targets (CAT). These patents provide methods and compositions for assessing, treating, and preventing diseases, especially cancer, using CAT. They also include techniques for determining or predicting the effectiveness of treatments for these diseases or for selecting appropriate treatments based on CAT. Furthermore, the patents describe methods for modulating cell function using CAT and include compositions that can modulate CAT, such as antagonists or agonists, including antibodies, proteins, small molecule compounds, and nucleic acid agents like RNAi and antisense agents. Additionally, the patents outline methods for screening agents that modulate CAT and the agents identified through these screening methods.

Career Highlights

Dong Fang is currently associated with Celera Corporation, where he continues to advance his research and innovations in cancer treatment. His work is pivotal in the ongoing fight against cancer, contributing to the development of new therapeutic strategies.

Collaborations

Some of his notable coworkers include Paul A Moore and Steve Ruben, who collaborate with him in various research initiatives.

Conclusion

Dong Fang's innovative work in cancer research exemplifies the impact of dedicated inventors in the medical field. His patents and ongoing contributions are vital in the quest for effective cancer treatments.